Net profit/loss of H. Lundbeck 2009-2019

The annual net profits or losses of the Danish pharmaceutical company H. Lundbeck fluctuated during the observed period. The largest losses were made in 2015, at around 5.7 billion Danish kroner. The following years, the company made profits that were increasing every year through to 2018. In 2018, the highest profits of the observed period was reached, of around 3.9 billion Danish kroner. In 2019, the profits decreased again to roughly 2.7 billion Danish kroner.

Annual net profit/loss of H. Lundbeck from 2009 to 2019

Net profit/loss in million DKK
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period

2009 to 2019

Supplementary notes

H. Lundbeck A/S is a Danish pharmaceutical company founded in 1915 with its headquarter in Copenhagen. Their key products are pharmaceuticals for the nervous system.

Some figures has been taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Denmark "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.